Landos Biopharma Inc at Jefferies Healthcare Conference Transcript
Hi, everybody. Thank you. We were just chit chatting. I apologize. My name is Chris Howerton, part of the Jefferies biotechnology research team, really excited to be hosting a little bit of a hybrid presentation here with the next company, Landos Biopharma.
On behalf of the company, we have the CEO, Greg Oakes. Go ahead, sir.
Thanks, Chris. Good morning, everyone. Great to see everyone bright and early on a Friday morning, first and foremost. So we appreciate the opportunity to be here with you today. I want to thank Chris and thank Jefferies for the for the opportunity.
As always, first and foremost, please refer to our forward-looking statements regarding today's presentation and the subsequent discussion.
A little bit about Landos Biopharma, we are a clinical-stage biopharmaceutical company focused on the development of novel new oral once-a-day therapeutics in the autoimmune space. Our mission is to create and develop new novel
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |